Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-01-15

Clinical Trial Update: Eplerenone in the Management of Abdominal Aortic Aneurysms [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update evaluating eplerenone for the management of abdominal aortic aneurysm; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eplerenone (eplerenone)

Snippet

Sponsor: Bayside Health | Conditions: Aortic Aneurysm, Abdominal | Phase 4 | Status: UNKNOWN